C0242339||Dyslipidaemia
C0036341||Schizophrenia
C0040615||Antipsychotics
C0028075||Nigeria
C0040615||antipsychotics
C0242339||dyslipidaemia
C0036341||schizophrenia
C0019994||Federal Neuropsychiatric Hospital
C0040615||antipsychotic
C0036341||schizophrenia
C0430044||fasting blood lipid profiles
C0451286||Medical Outcome Study Short Form General Health Survey
C0430044||Fasting lipid profile
C0543421||total cholesterol
C0543421||total cholesterol
C0023823||low density lipoprotein
C0023823||low density lipoprotein
C0041004||triglycerides
C0041004||triglycerides
C0543421||total cholesterol
C0023823||LDL
C0041004||triglycerides
C0023821||high density lipoprotein
C0023821||high density lipoprotein
C0242339||dyslipidaemia
C0543421||total cholesterol
C0023823||LDL
C0041004||triglycerides
C0023821||high density lipoprotein
C0543421||total cholesterol
C0023823||LDL
C0041004||triglycerides
C0023821||high density lipoprotein
C0080105||Subjects
C0040615||antipsychotics
C0242339||dyslipidaemia
C0040615||antipsychotics
C0242339||dyslipidaemia